Skip to content

A study looking at what increases the risk of high blood pressure during pregnancy and how medicines are used to manage it

A prospective observational study on risk factors and drug utilization patterns in women with pregnancy induced hypertension - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/03/083106
Enrollment
100
Registered
2025-03-21
Start date
Unknown
Completion date
Unknown
Last updated
2025-04-07

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O134- Gestational [pregnancy-induced] hypertension without significant proteinuria, complicating childbirth

Interventions

Intervention1: NOT APPLICABLE: NOT APPLICABLE

Sponsors

Dr Smruti Vaishnav
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Pregnant women diagnosed with pregnancy induced hypertension, Patient giving consent

Exclusion criteria

Exclusion criteria: Patient age less than 18 years, Pregnant women not diagnosed with pregnancy induced hypertension, Patient not giving consent

Design outcomes

Primary

MeasureTime frame
To identify and analyze risk factors associated with Pregnancy Induced Hypertension. To characterize and evaluate the drug utilization patterns associated with Pregnancy Induced Hypertension. Timepoint: 6 MONTHS

Secondary

MeasureTime frame
To evaluate relative adverse events associated with Pregnancy Induced Hypertension.Timepoint: 6 MONTHS

Countries

India

Contacts

Public ContactDr. Smruti Vaishnav

Anand Pharmacy College

punitbjoshi52@gmail.com9820162313

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026